C4XD names Piers Morgan, CEO
This article was originally published in Scrip
Executive Summary
C4X Discovery, a drug discovery and design spin-out firm from the University of Manchester, has appointed Piers Morgan chief executive officer. Mr Morgan has also been appointed a member of the Manchester, UK-based company's board of directors. He succeeds Dr Sam Williams, who will resume his previous role as a non-executive director of the company. Prior to joining C4XD Mr Morgan was chief financial officer at UniQure, a gene therapy company.